Amira Barkal

Amira Barkal is the Principal Founder and Interim CEO at Pheast Therapeutics. Amira has over two years of experience as a Technical Research Assistant at Brigham and Women's Hospital. In this role, they were responsible for conducting research and experiments, as well as writing reports on their findings. Amira has a strong background in biology and chemistry, which has helped their to be successful in their current role.

Amira Barkal has a Ph.D. in Stem Cell Biology & Regenerative Medicine from Stanford University School of Medicine. Amira also has an M.D. from Stanford University School of Medicine. Amira has a B.Sc. in Biochemistry and Biophysics from Oregon State University.

Some individuals on their team include Roy Maute - Co-Founder & Chief Scientific Officer, Jennifer Yinuo Cao - Associate Director of Discovery, and Tiffany van Londen - Operations Manager.